Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sheel BiotechNSE:SHEEL 18 EBIT per Share is ₹9.07 as of Mar. 2026. GuruFocus rates NSE:SHEEL with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 1,583 Consumer Packaged Goods companies, Sheel Biotech ranks better than 77.57% on this metric.
Sheel Biotech's EBIT per Share for the
six
months ended in Mar. 2026 was ₹9.07.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹9.07.
During the past 12 months, the average EBIT per Share Growth Rate of Sheel Biotech was 25.30% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 30.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Sheel Biotech's EBIT per Share or its related term are showing as below:
NSE:SHEEL'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 30.6 Med: 33.9 Max: 37.2
Current: 30.6
During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Sheel Biotech was 37.20% per year. The lowest was 30.60% per year. And the median was 33.90% per year.
NSE:SHEEL's 3-Year EBIT Growth Rate is ranked better than 77.57% of 1583
companies
in the Consumer Packaged Goods industry
Industry Median: 6.9
vs NSE:SHEEL: 30.60
Sheel Biotech's EBIT for the
six
months ended in Mar. 2026 was ₹159 Mil.
Sheel Biotech (NSE:SHEEL) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Sheel Biotech EBIT per Share Related Terms
Sheel Biotech EBIT per Share Historical Data
* Premium members only.
The historical data trend for Sheel Biotech's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹9.07
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech (NSE:SHEEL) has a EBIT per Share of ₹9.07 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Sheel Biotech and its competitors. According to the industry distribution chart, Sheel Biotech ranks #355 out of 1583 companies in the Consumer Packaged Goods industry, placing it in the top 22.4%.
Is Sheel Biotech's EBIT per Share too high?
Sheel Biotech's current EBIT per Share is ₹9.07. Based on the distribution chart, Sheel Biotech ranks #355 out of 1583 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Sheel Biotech has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's EBIT per Share compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Sheel Biotech ranks #355 out of 1583 companies for EBIT per Share. This places Sheel Biotech in the top 22% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 6.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Consumer Packaged Goods company?
The median EBIT per Share among Consumer Packaged Goods companies is 6.90, based on 1,583 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Sheel Biotech and its competitors. For the Consumer Packaged Goods industry, the median EBIT per Share is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sheel Biotech's current EBIT per Share is ₹9.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current EBIT per Share of ₹9.07. The current EBIT per Share is ₹9.07. Sheel Biotech's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current EBIT per Share is ₹9.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
18GF Score
Get the complete analysis for NSE:SHEEL
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SHEEL has been successfully added to your 
